Thursday, May 12, 2011

Cell Biosciences Acquires Canadian Firm

Santa Clara-based Cell Biosciences, a developer of scientific equipment for protein analysis, said Thursday that it has acquired Brightwell Technologies, in a deal worth $9M in cash. Brightwell was based in Ottawa, Ontario, and develops micro-flow imaging analytics equipment. Cell Biosciences said Brightwell's expected 2011 revenues are approximately $5M; Brightwell had 30 employees. As part of the acquisition, Cell Biosciences said it raised $13M in a second tranche of its Series F funding, from Essex Woodlands Health Ventures, Novo A/S, Domain Associates, Latterell Venture Partners, Royal Bank of Canada, The Vertical Group and Lansing Brown Investments.